Trials / Completed
CompletedNCT02299544
BlueWind Medical System for the Treatment of Patients With OAB
Safety and Performance of the BlueWind System for the Treatment of Patients With Overactive Bladder (OAB) Amended to Allow Extended Follow up of the Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- BlueWind Medical · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
BlueWind system safety and performance in treatment of patients diagnosed with overactive bladder (OAB)
Detailed description
BlueWind Medical system safety and performance in treatment of patients diagnosed with overactive bladder (OAB)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BlueWind Medical system | The BlueWind Medical System is intended for the treatment of patients with overactive bladder (OAB) including urinary urgency frequency and urge incontinence. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2018-08-01
- Completion
- 2018-12-01
- First posted
- 2014-11-24
- Last updated
- 2019-06-18
Locations
6 sites across 2 countries: Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT02299544. Inclusion in this directory is not an endorsement.